If you are searching for legit peptides UAE — specifically tesamorelin Dubai with same-day delivery — you have landed in the right lab notebook. REVIVE LAB UAE is the UAE-based research peptides supplier stocking tesamorelin 5mg and tesamorelin 10mg vials with 24h delivery Dubai-wide and cold-chain courier from Abu Dhabi to Ras Al Khaimah. This post unpacks the exact 16-week tesamorelin protocol UAE research teams keep asking us about — the one modelled on Stanley 2014 — so you can plan dosing, bloods and VAT measurement before you buy tesamorelin 5mg in Dubai from us.
Tesamorelin is a growth hormone releasing hormone (GHRH) analog. Unlike exogenous GH, it works upstream — restoring pulsatile GH and downstream IGF-1 without flattening the diurnal curve. That is why the 16-week window matters: it is long enough to register visceral adipose tissue (VAT) change on imaging, short enough to be a clean research arc, and it lines up with the published Stanley and Falutz datasets.
The Stanley 2014 follow-up published in The Journal of Clinical Endocrinology & Metabolism tracked HIV-associated lipodystrophy subjects on 2 mg SC tesamorelin daily. Earlier Falutz 2007 (NEJM) and Falutz 2010 datasets had already shown VAT reductions in the 15-18% range at 26 weeks — but the inflection point sits around weeks 12-16. By week 16 the average VAT delta in responders is roughly two-thirds of the 26-week endpoint, while IGF-1 has already plateaued. For a UAE-based research run, 16 weeks is the sweet spot between meaningful signal and protocol fatigue.
Translation for the bench: if your model is not moving by week 16, the rest of the curve is unlikely to rescue it. Reallocate, re-reconstitute, or extend a second arm. The REVIVE Peptides UAE catalog is built around this kind of decision — short-cycle, data-driven, no waste.
Below is the canonical 16-week tesamorelin research framework. All numbers reflect Stanley 2014's 2 mg SC daily arm. This is research-use only, IRB protocol territory — not medical advice.
| Week | Dose | Schedule | Markers to Pull |
|---|---|---|---|
| Baseline | — | — | IGF-1, fasting glucose, HbA1c, lipid panel, CT/MRI VAT |
| 1-4 | 2 mg SC | Daily evening | Week 4: IGF-1, fasting glucose |
| 5-8 | 2 mg SC | Daily evening | Week 8: IGF-1, lipid panel |
| 9-12 | 2 mg SC | Daily evening | Week 12: IGF-1, HbA1c, fasting glucose |
| 13-16 | 2 mg SC | Daily evening | Week 16: full repeat panel + CT/MRI VAT |
Inject subcutaneously into rotating abdominal sites, evening, on an empty stomach. Weekly SC alternatives have been trialled but the Stanley dataset is built on daily — stick to daily if you want comparability.
Here is what the Stanley 2014 and Falutz 2010 arms showed at the 16-week milestone. Your milage will vary with model, baseline VAT, and assay sensitivity — but this is the published envelope.
| Marker | Baseline Range | Week 16 Expected Shift | Notes |
|---|---|---|---|
| IGF-1 (ng/mL) | 120-180 | +80 to +120% | Plateaus around week 8-10 |
| VAT (cm² on CT) | baseline | -10 to -13% | Two-thirds of 26-week endpoint |
| Triglycerides (mg/dL) | baseline | -15 to -50 | Falutz 2010 dataset |
| Fasting glucose (mg/dL) | baseline | +2 to +5 | Monitor — small upward drift typical |
| HbA1c (%) | baseline | +0.1 to +0.2 | Clinically modest; flag if >0.4 |
| Lean mass (kg) | baseline | +0.5 to +1.5 | Preserved or modestly increased |
The glucose drift is the headline caveat. GHRH analogs nudge insulin sensitivity in the wrong direction; that is why HbA1c monitoring at weeks 12 and 16 is non-negotiable in any serious tesamorelin protocol UAE researchers run. Pulsatile GH gain comes at a small carb-handling cost — design your arm around it.
Compared with CJC-1295 or sermorelin, tesamorelin has the longest published human dataset and the only peptide with NEJM-level VAT outcome data. CJC has the half-life advantage; sermorelin has the price advantage; tesamorelin has the evidence advantage. For UAE researchers wanting a 16-week arc with citeable endpoints, tesamorelin is the default. The REVIVE Peptides UAE inventory carries the 5 mg vial for short pilots and the 10 mg vial for full 16-week arms — both with HPLC certificate of analysis attached.
REVIVE LAB UAE dispatches tesamorelin in insulated cold-chain packaging from our Dubai hub. Order before 2 PM, get it the same day across most of the UAE.
REVIVE Peptides UAE is the UAE-based research peptides supplier behind revivelab.ae. Every batch ships with a third-party HPLC certificate, every vial moves under cold chain, and every order is packed discreetly. We stock the bestsellers — tesamorelin, retatrutide, GHK-Cu — in real depth so you do not get hit with "out of stock" mid-protocol. Browse all REVIVE Peptides UAE products or jump straight to the REVIVE LAB UAE tesamorelin 5 mg and 10 mg vials.
REVIVE LAB UAE stocks tesamorelin 5 mg and 10 mg vials with same-day cold-chain dispatch across Dubai, Abu Dhabi, Sharjah and Ajman, and 24h delivery to RAK, Fujairah and Al Ain. Order tesamorelin Dubai before 2 PM for same-day arrival.
The Stanley 2014 lipodystrophy follow-up trial used 2 mg subcutaneous tesamorelin daily for 26 weeks. The 16-week observational window of that protocol is when most VAT reduction becomes measurable on CT imaging.
Yes — tesamorelin cash on delivery UAE is supported across Dubai, Abu Dhabi and Sharjah. Discreet packaging, anonymous shipping, insulated cold-chain courier on every order.